FedEx Freight Spinoff: FDXF Valuation and the Remaining FedEx Stub

Key Takeaways

• FDXF trades at $152, valuing freight at $22.6 billion.
• Enterprise value of FDXF is $26.7 billion, 3.1× FY2026 revenue.
• FedEx retained 19.9% FDXF stake, worth about $4.5 billion.
• Parent FedEx stub valued ~ $74 billion, 9× FY2029 operating income.
• Success hinges on FedEx Freight margin improvement and FedEx’s margin targets.

Pulse Analysis

Spinoffs have become a favored tool for conglomerates seeking to unlock hidden value, and FedEx’s decision to separate its less‑than‑truckload (LTL) business follows a wave of logistics restructurings. By carving out FedEx Freight, the company not only creates a pure‑play LTL ticker but also isolates a segment that historically trades at lower multiples than the high‑growth express and parcel units. The market’s immediate reaction—pricing FDXF at $152 and assigning a $22.6 billion equity value—signals that investors view the freight operation as a sizable, stand‑alone asset rather than a peripheral holding.

FDXF’s valuation translates to roughly 3.1× FY2026 revenue and 24× adjusted operating income, multiples that sit between the discount of a typical LTL carrier and the premium of a high‑margin logistics platform. Compared with peers such as Old Dominion (≈12% margin) and XPO (≈10% margin), FedEx Freight must lift its operating ratio to justify the price. The company’s 2026 targets of 12.6% operating margin and modest revenue growth set a clear performance hurdle; failure to close the gap could leave the stock over‑priced relative to its peers.

The more intriguing narrative is the parent stub, now valued at about $74 billion after stripping the freight stake. Management’s FY2029 goal of $8 billion operating income—an 8% margin on $98 billion revenue—implies a roughly 9× earnings multiple, a modest premium to historical levels if the targets are met. Should FedEx deliver on these margins, the retained 19.9% stake in FDXF, worth roughly $4.5 billion, becomes a sweetener for shareholders. Conversely, any shortfall would keep the parent’s valuation constrained, making the spinoff a diagnostic rather than a cure.